Dante J. Marciani - Concepedia

Author

Dante J. Marciani

Also Known As

D J Marciani, D MARCIANI, D Marciani, D. J. Marciani, D. Marciani, D.J. Marciani, DANTE J. MARCIANI, Dante J Marciani, Dante J. Marciani, Dante Juan Marciani

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Southern Research Institute Galena Biopharma (United States)ECI Biotech (United States)National Cancer Institute University of Alabama at Birmingham

About

Dante J. Marciani is an author at Southern Research Institute specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	833
2	Biochemistry	6	6	172
3	Natural Sciences	5	5	162
4	Allergy	1	1	40
5	Biology	1	1	79

Dante J. Marciani

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex Charlotte R. Kensil, Urmila H. Patel, Michael Lennick, The Journal of Immunology	1991	648
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma Philip O. Livingston, Sucharita Adluri, Friedhelm Helling, Vaccine VaccinationMelanomaImmunologyTumor ImmunityPathology	1994	214
Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity Dante J. Marciani, Jeffery B. Press, Robert C. Reynolds, Vaccine InflammationPhytoalexinAnti-inflammatoryMedicineImmunology	2000	195
Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats Dante J. Marciani, Charlotte R. Kensil, Gerald A. Beltz, Vaccine VaccinationVeterinary VaccineGenetically-engineered Subunit VaccineVaccine DevelopmentVaccine Research	1991	91
Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins Dante J. Marciani, Ashish K. Pathak, Robert C. Reynolds, International Immunopharmacology BiologyPhytoalexinAltered ImmunomodulatingToxicologyMicrobiology	2001	79
Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100 Dante J. Marciani, Robert C. Reynolds, Ashish K. Pathak, Vaccine Bioorganic ChemistryBiochemistryNatural SciencesMolecular BiologyImmunological Characterization	2003	69
Cell-free synthesis of the precursor polypeptide for avian myeloblastosis virus DNA polymerase. Brett M. Paterson, Dante J. Marciani, Takis S. Papas Proceedings of the National Academy of Sciences	1977	56
Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody Richard M. Thorn, Gerald A. Beltz, Chien‐Hui Hung, Journal of Clinical Microbiology Primary ImmunodeficiencyUnique AntigenHuman Immunodeficiency VirusNeurovirologyHuman Retrovirus	1987	45
Detection of antibodies to human immunodeficiency virus by latex agglutination with recombinant antigen Charles H. Riggin, Gerald A. Beltz, Chien‐Hui Hung, Journal of Clinical Microbiology VaccinationHuman Immunodeficiency VirusAllergyLatex AgglutinationHuman Retrovirus	1987	40
DS-1, a Modified Quillaja Saponin, Enhances Ocular and Nasal Absorption of Insulin Dennis J. Pillion, Joanne Recchia, Ping Wang, Journal of Pharmaceutical Sciences OphthalmologyMedicineDiabetesPhysiologyEnhances Ocular	1995	36

Page 1